Does the Cetuximab Plus Paclitaxel Combination Deserve to Be Studied in a Phase III Trial? Reply

作者:Wong, Yu-Ning*; Plimack, Elizabeth R.; Litwin, Samuel; Vaughn, David; Lee, James; Song, Wei; Hudes, Gary R.
来源:Journal of Clinical Oncology, 2013, 31(12): 1615-1616.
DOI:10.1200/JCO.2012.47.8255
  • 出版日期2013-4-20

全文